Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Can-Fite gets $9.85mm with IPO

Executive Summary

Israeli biotech Can-Fite BioPharma (oral small-molecule therapeutics) raised $9.85mm through an oversubscribed initial public offering of about 133k units priced at $73.88 each. Each unit consists of 300 common shares and two-year warrants to buy 100 shares at $0.30 apiece. The company will trade on the Tel Aviv exchange.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies